Michael Eisenstein

Verified

Writer and Editor, Freelance

Health, Opinion and Editorial, Science, U.S.

As seen in: British Journal of Cancer, Nature, Weird Fiction Review Edu, Scientific American, American Chemical Society, Chemical & Engineering News (C&EN), The Hub (Johns Hopkins University), Science Magazine, Medical Xpress, BioRxiv and

Covers: Biology, Medicine, Genomics, Biotechnology, Drug Development, Research Policy, Bioethics, Regenerative Medicine, Oncology, Synthetic Biology, Immunotherapy

Science writer and editor. Done with this place. Find me on BlueSky, same name.

Back to Michael Eisenstein’s profile

Michael Eisenstein’s Journalist Portfolio

View as a list

Single-cell RNA-seq analysis software providers scramble to offer solutions

A raft of tools have sprung up to help biologists work through the single-cell transcriptomic bottleneck, but…

View article →

Rewriting the regenerative rulebook

Adult stem cells have become a regulatory battleground as clinicians, scientists and ethicists debate whether…

View article →

Pursuing the simple life

Efforts to pare away cellular genomes are yielding streamlined biosynthetic factories and deeper insights int…

View article →

Organoids: the body builders

Stem-cell-derived organoids offer increasingly sophisticated models for studying human development and diseas…

View article →

How social scientists can help to shape climate policy

Developing strategies to ensure that the ‘needs of the few’ do not outweigh those of the rest.

View article →

An ace in the hole for DNA sequencing

Offering long reads and rapidly improving accuracy, nanopore sequencing has the potential to upend the DNA se…

View article →

Artificial intelligence powers protein-folding predictions

Deep-learning algorithms such as AlphaFold2 and RoseTTAFold can now predict a protein's 3D shape from its lin…

View article →